| Q39822481 | Acebutolol. A review of its pharmacological properties and therapeutic efficacy in hypertension, angina pectoris and arrhythmia |
| Q40311396 | Adverse effects of antihypertensive drugs |
| Q40327667 | Anesthesia for the high risk obstetric patient. |
| Q36714542 | Anti-hypertensive therapy with propranolol during pregnancy and lactation |
| Q77299228 | Antiarrhythmic drug therapy in pregnancy and lactation |
| Q34449754 | Atenolol in the treatment of pregnancy‐induced hypertension |
| Q44149485 | Behavioral and biochemical studies in rats following prenatal treatment with β-adrenoceptor antagonists |
| Q72557491 | Beta Blocker Therapy in 125 Cases of Hypertension During Pregnancy |
| Q68092407 | Beta-adrenergic receptor blockade in the management of pregnant women with mitral stenosis |
| Q40091895 | Beta-adrenoceptor blocking drugs: Adverse reactions and drug interactions |
| Q39728667 | Carbohydrate metabolism in the fetus and neonate and altered neonatal glucoregulation |
| Q35883940 | Cardiac arrhythmias in the human fetus |
| Q61591110 | Clinical and pharmacologic study of fetal supraventricular tachyarrhythmias |
| Q70818031 | Combined use of beta-sympathomimetic drugs and beta-blockers during labour |
| Q35704266 | Comparative risk-benefit assessment of drugs used in the management of hypertension in pregnancy |
| Q34045784 | Drug therapy for hyperthyroidism in pregnancy: safety issues for mother and fetus |
| Q34511028 | Drug treatment of fetal tachycardias |
| Q37105405 | Drug-Induced Cardiovascular Diseases |
| Q37799813 | Drug-induced hypoglycaemia: an update |
| Q39553659 | Drugs in pregnancy: effects on the fetus and newborn |
| Q39806262 | Effect of Drugs on Intrauterine Growth |
| Q39124737 | Effect of propranolol infusion on the umbilical and uterine circulations of pregnant sheep |
| Q70432218 | Effect of propranolol treatment in pregnant rats on motor activity and avoidance learning of the offspring |
| Q41375847 | Effects of racemic, dextro-laevo-propranolol and isoxuprine on the metabolic and endocrine response to cold in the newborn rabbit |
| Q44227501 | Effects on the neonate of propranolol administered during pregnancy |
| Q38001011 | Endocrine disease and pregnancy |
| Q39439669 | Experience with the use of propranolol in the surgical management of thyrotoxicosis |
| Q72503543 | Fetal Cardiovascular Reactions During Labour and Asphyxia Modified by Adrenergic Receptor Agonists and Antagonists |
| Q40109250 | Fetal Drug Exposure—Behavioral Teratogenesis |
| Q39260629 | Fetal effects of antihypertensive drugs |
| Q35118456 | First year of life after the use of atenolol in pregnancy associated hypertension |
| Q69432342 | Half-life of maternal labetalol in a premature infant |
| Q69551664 | Hyperthyroidism in pregnancy |
| Q40307314 | Intrapartum management of the cardiac patient. |
| Q35603163 | Intrauterine supraventricular tachyarrhythmias and transplacental digitalisation |
| Q39896705 | Intrauterine supraventricular tachycardia |
| Q28330251 | Long-term propranolol therapy in pregnancy: Maternal and fetal outcome |
| Q39662631 | Management of cardiac arrhythmias during pregnancy. Current concepts |
| Q30660899 | Management of glaucoma in pregnancy and lactation |
| Q67018864 | Management of pregnancy in patients with hypertrophic cardiomyopathy |
| Q39723154 | Maternal-fetal considerations in hyperthyroidism |
| Q40088644 | Medical treatment of cardiovascular disorders during pregnancy |
| Q34785089 | Neonatal effects of maternal administration of acebutolol |
| Q39700201 | Peritoneal dialysis and haemodialysis in pregnancy |
| Q40090048 | Pindolol: A Review of Its Pharmacology, Pharmacokinetics, Clinical Uses, and Adverse Effects |
| Q33534326 | Pregnancy in chronic renal insufficiency and end-stage renal disease |
| Q43635449 | Pregnancy in patients with heart disease: experience with 1,000 cases |
| Q40631324 | Pregnancy in women on haemodialysis and peritoneal dialysis |
| Q58812880 | Propranolol in Pregnancy Three Year Prospective Study |
| Q41474294 | Propranolol in human plasma and breast milk |
| Q28332973 | Propranolol therapy during pregnancy, labor, and delivery: evidence for transplacental drug transfer and impaired neonatal drug disposition |
| Q49911796 | Randomised comparison of methyldopa and oxprenolol for treatment of hypertension in pregnancy |
| Q35288076 | Randomised controlled trial of effect of terbutaline before elective caesarean section on postnatal respiration and glucose homeostasis |
| Q70771965 | Successful Treatment of Fetal Congestive Heart Failure Secondary to Tachycardia |
| Q40084525 | Teratogenesis: A Review of the Basic Principles with a Discussion of Selected Agents: Part II |
| Q72503537 | The Autonomic Nervous System and Perinatal Metabolism |
| Q72492403 | The Treatment of Hypertension in Pregnancy |
| Q70338021 | The developing liver: the steady-state disposition of propranolol in pregnant sheep |
| Q36715451 | The management of thyroid disease in pregnancy |
| Q66933572 | The treatment of benign thyroid disease |
| Q37040071 | Thyroid Function and Hyperfunction in the Pregnant Woman |
| Q41697406 | Thyroid disease in women |
| Q48129985 | Transplacental and mammary passage of radioactivity in rats treated vaginally and orally with [14C]propranolol |
| Q67247510 | Treatment of hypertension in pregnancy |
| Q34450326 | Treatment of hypertension in pregnancy with beta-adrenoceptor antagonists |
| Q38639052 | Use of medication for cardiovascular disease during pregnancy |